ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
otherperspective
|
384 |
181K |
107 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
384
|
181K
|
107
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
otherperspective
|
867 |
399K |
55 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
867
|
399K
|
55
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
otherperspective
|
867 |
399K |
35 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
867
|
399K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
otherperspective
|
867 |
399K |
53 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
867
|
399K
|
53
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
otherperspective
|
867 |
399K |
97 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
867
|
399K
|
97
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
otherperspective
|
384 |
181K |
57 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
384
|
181K
|
57
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
otherperspective
|
384 |
181K |
67 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
384
|
181K
|
67
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
otherperspective
|
384 |
181K |
117 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
384
|
181K
|
117
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
12K |
3.9M |
67 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
12K
|
3.9M
|
67
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
12K |
3.9M |
112 |
21/07/24 |
21/07/24 |
ASX - By Stock
|
12K
|
3.9M
|
112
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
12K |
3.9M |
71 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
12K
|
3.9M
|
71
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
12K |
3.9M |
108 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
12K
|
3.9M
|
108
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to File BLA for Ryoncil FDA Approval Next Week
|
|
otherperspective
|
181 |
82K |
62 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
181
|
82K
|
62
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
7.1M |
55 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
18K
|
7.1M
|
55
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
otherperspective
|
1.0K |
453K |
126 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.0K
|
453K
|
126
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
otherperspective
|
1.0K |
453K |
75 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
1.0K
|
453K
|
75
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
otherperspective
|
614 |
122K |
21 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
614
|
122K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
otherperspective
|
245 |
98K |
55 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
245
|
98K
|
55
|
|
ASX - By Stock
|
MSB |
Re:
Bell Potter Conference Up dates?
|
|
otherperspective
|
245 |
98K |
98 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
245
|
98K
|
98
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Outstanding 98.6% Success Rate in Striate Implant Study
|
|
otherperspective
|
32 |
12K |
39 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
32
|
12K
|
39
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
otherperspective
|
729 |
257K |
31 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
729
|
257K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
otherperspective
|
1.3K |
431K |
74 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
1.3K
|
431K
|
74
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
otherperspective
|
1.3K |
431K |
109 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
1.3K
|
431K
|
109
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
otherperspective
|
1.3K |
431K |
99 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
1.3K
|
431K
|
99
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
otherperspective
|
1.3K |
431K |
54 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
431K
|
54
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
otherperspective
|
1.3K |
431K |
64 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
1.3K
|
431K
|
64
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
otherperspective
|
943 |
417K |
112 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
943
|
417K
|
112
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
7.1M |
53 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
18K
|
7.1M
|
53
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
otherperspective
|
274 |
111K |
49 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
274
|
111K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
otherperspective
|
1.0K |
453K |
61 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
1.0K
|
453K
|
61
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
otherperspective
|
1.0K |
453K |
94 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.0K
|
453K
|
94
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
otherperspective
|
154 |
52K |
49 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
52K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
otherperspective
|
549 |
190K |
64 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
190K
|
64
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
otherperspective
|
549 |
190K |
73 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
190K
|
73
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
otherperspective
|
549 |
190K |
84 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
190K
|
84
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Financial Results Presentation
|
|
otherperspective
|
78 |
27K |
77 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
78
|
27K
|
77
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
12K |
3.9M |
82 |
21/02/24 |
21/02/24 |
ASX - By Stock
|
12K
|
3.9M
|
82
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
12K |
3.9M |
63 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
12K
|
3.9M
|
63
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
otherperspective
|
12K |
3.9M |
59 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
12K
|
3.9M
|
59
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
otherperspective
|
513 |
139K |
49 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
513
|
139K
|
49
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
otherperspective
|
513 |
139K |
70 |
31/12/23 |
31/12/23 |
ASX - By Stock
|
513
|
139K
|
70
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
otherperspective
|
716 |
210K |
71 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
716
|
210K
|
71
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Files for FDA Designations in Congenital Heart Disease
|
|
otherperspective
|
68 |
24K |
92 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
68
|
24K
|
92
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
otherperspective
|
18K |
7.1M |
57 |
07/11/23 |
07/11/23 |
ASX - By Stock
|
18K
|
7.1M
|
57
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Report to Shareholders
|
|
otherperspective
|
74 |
25K |
89 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
74
|
25K
|
89
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
otherperspective
|
574 |
204K |
23 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
204K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Type A Meeting with FDA
|
|
otherperspective
|
574 |
204K |
104 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
574
|
204K
|
104
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
otherperspective
|
3.4K |
1.2M |
42 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
42
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Update
|
|
otherperspective
|
60 |
25K |
61 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
60
|
25K
|
61
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
otherperspective
|
913 |
303K |
70 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
913
|
303K
|
70
|
|